ArticleCureus2024
Exacerbation of Hyperbilirubinemia by Falciparum Malaria in a Patient With Coexisting Gilbert's Syndrome and Glucose-6-Phosphate Dehydrogenase Deficiency.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gilbert's syndrome and G6PD deficiency are common genetic disorders. They both give rise to unconjugated hyperbilirubinemia through different mechanisms. Falciparum malaria-induced hemolysis is another cause of unconjugated hyperbilirubinemia. We have reported a 51-year-old Asian male who presented with a four-day history of fever and sweating just after a holiday in Kenya. He admitted to not taken malaria prophylaxis while on holiday. Initial investigations revealed that he had falciparum malaria along with co-existing severe G6PD deficiency and Gilbert's syndrome, which we believe, all contributed to an exacerbation of unconjugated hyperbilirubinemia (four-fold rise). He was treated with intravenous fluids, paracetamol and oral artemether/lumefantrine combination therapy. He made a good clinical recovery. After a month, he still exhibited chronic unconjugated hyperbilirubinemia with recurrent elevation in his reticulocyte count but no anaemia, suggesting further episodes of compensated hemolysis. We also discuss the differential diagnosis for unconjugated hyperbilirubinemia in relation to this interesting case.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.